Friday, August 24, 2018

Erlotinib as adjuvant therapy in EGFR-mutant NSCLC https://t.co/pV1K82JER6


from Twitter https://twitter.com/PeerMarisa

August 24, 2018 at 12:40PM
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)